ACTA NEUROPHARMACOLOGICA››2011,Vol. 1››Issue (3): 41-46.
Previous ArticlesNext Articles
Zhou Xiao-wen1, Su Chao-fen1, Luo Huan-min1 2
Online:
2011-06-26Published:
2012-06-28CLC Number:
Zhou Xiao-wen, Su Chao-fen, Luo Huan-min.Mitochondria and Neurodegenerative Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(3): 41-46.
1 Appel SH, Smith RG, Le WD. Immune-mediated cell death in neurodegenerative disease[J].Adv Neurol,1996, 69:153-159 2 John Hardy. Pathways to primary neurodegenerative disease[J]. Neurologia,2002,17(8):399-401 3 朱兴族.神经退行性疾病病变机理及药物作用新靶点.科技前沿与学术评论[J],1999,21(6):42-46 4 高欣,唐希灿.神经退行性疾病的早期信号:线粒体功能障碍[J].生命科学,2006,18(2):138-143 5 张均田.脑缺血、葡萄糖/能量代谢障碍与神经退行性疾病[J]. 中国药理通讯, 2000(16):241-246 6 Minoshima S, iordani B, Berent S,et al. Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease[J]. Ann Neurol, 1997(42):85-94 7 Ellen A A Nollen, Richard Morimoto. Chaperoning signaling pathways: molecular chaperones as stress-sensing ‘heat shock’ proteins[J].J Cell Sci,2002(115):2809-2816 8 辛颖.线粒体与神经退行性病变[J].医学综述,2008,14(4):520-521 9 Mahyar Etrninan,Sudeep S Gill,Ali Samii. Intake of vitamin E,vitamin C,and carotenoids and the risk of Parkinson’S disease:a metaanalysis[J]. Lancet Neurol, 2005(4):362-365 10 Edgar R. Miller, Pastor-Barriuso Pastor, Darshan Dalai,et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality[J]. Ann Int Med, 2005(142):37-46 11 Enrique Cadenas, Kelvin J.A.Davies. Mitochondrial free radical generation, oxidative stress, and aging[J]. Free Radic BiolMed, 2000(29): 222-230 12 韩玲,陈可冀.氧应激对线粒体呼吸链的影响及益心康的作用[J]. 中国心血管病杂志,2002,7(2):115-117 13 刘新,邹典定,王大斌,明萌,刘志祥.海马神经元兴奋性毒性模型的建立及其意义[J]. Stroke and Nervous Diseases,2006,13(3):138-141 14 许康,张苏明.线粒体损伤与神经元缺血死亡[J].国外医学脑血管疾病分册,2002,10(6):461-464 15 Dae-Won Seo, Maria-Leonor Lopez-Meraz, Suni Allen, Claude Guy Wasterlain, Jerome Niquet. Contribution of a mitochondrial pathways to excitotoxic neuronal necrosis[J]. J Neurosci Res, 2009, 87(9): 2087–2094 16 Dong Xiaoxia, Wang Yan, Qin Zhenghong. Molecular mechanism s of excitotoxicity and their relevance to pathogenesis of rodegenerative diseases[J]. Acta Pharmacol Sin, 2009(4):379~387 17 唐小卿,赵静,杨春涛,申新田等.非对称性二甲基精氨酸保护PC12细胞拮抗谷氨酸兴奋性毒性的损伤作用[J].中国病理生理杂志,2009 ( 2): 248- 253 18 Michael T.Lin, M.Flint Beal. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases[J]. Nature,2006,443 (7113): 787–795 19 Douglas R.Green, Guido Kroemer. The pathophysiology of mitochondrial cell death[J]. Science, 2004,305(5684): 626-629 20 Celine Cande, Francesco Cecooni, Philippe Dessen,et al. Apoptosis-inducing factor(AIF):key to the caspase independent pathways of cell death[J]. J Cell Sci, 2002,115(24):4727-4734 21 Ryuji Hata , Keiichiro Maeda , Dirk Hermann,et al. Evolution of brain infarction after transient focal cerebral ischemia in mice[J]. J Cereb Blood Flow Metab,2000(20):937-946 22 李宜培.线粒体损伤与细胞凋亡[J].河南职工医学院学报,2008,20(1):94-97 23刘志安,赵娓娓,吕春娥,李梅,徐铁军. AD样大鼠海马NMDAR亚单位2B和2A的表达及其与细胞凋亡的关系[J].山东大学学报,2011(2):14-18. 24 刘新红,周广安. 原位杂交检测FADD和TH mRNA在PD模型大鼠黑质中的表达变化及与凋亡的关系[J].泰山医学院学报,2011(4):254-256. 25 P.Hemachandra Reddy. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer′s disease[J]. Exp Neurol, 2009, 218(2): 286-292 26 Gjumrakch Aliev, Eldar Gasimov, Mark E Obrenovic,et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer’s disease[J]. Vasc Health Risk Manag, 2008(4):721–730 27 Latha Devi , Hindupur K. Anandatheerthavarada . Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases[J]. Biochim Biophys Acta, 2010( 1802):11–19 28 Querfurth HW, LaFerla FM. Alzheimer’s disease[J]. N Engl J Med, 2010 (362):329–344 29 Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities[J]. J Neurochem, 2002(80):91-100 30 Casley CS, Land JM, Sharpe MA, Clark JB, Duchen MR, Canevari L. Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons[J]. Neurobiol Dis,2002(10):258-267 31 Casper Caspersen, Wang Ning, Yao Jun,et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease[J]. FASEBJ,2005(19):2040–204 32 Virginie Rhein , Song Xiaomin, Andreas Wiesner,et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice[J]. Proc Natl Acad Sci USA , 2009,(106):20057–20062 33 Gunnar K Gouras, Claudia G Almeida, Reisuke Takahashi. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer’s disease[J]. Neurobiol Aging, 2005(26):1235–1244 34 Peter J.Crouch, Rachel Blake, James A.Duce,et al. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta 1–42[J].J Neurosci,2005(25):672–679 35 Patricia A Trimmer, Paula M Keeney, M Kate Borland,et al. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer’s disease worsen with passage in culture[J]. Neurobiol Dis, 2004(15):29–39 36 徐淑君,刘桂兰. β淀粉样蛋白导致的线粒体损伤研究进展[J].生物化学与生物物理进展,2010,37(6):589-593 37 Vanessa A Morais, De Strooper Bart. Mitochondria dysfunction and neurodegenerative disorders: Cause or Consequence[J]. J Alzheimers Dis, 2010(20): S255–S263 38 Choudhary S, Zhang W, Zhou F,et al. Cellular lipid peroxidation endroducts induce apoptosis in human lens epithelial cells[J].Free Radic Biol Med,2002(32):360 – 3691 39 David C Chan. Mitochondrial fusion and fission in mammals[J].Ann Rev Cell Dev Biol ,2006(22):79–99 40. Wang Xinglong, Su Bo, Hisashi Fujioka, Zhu Xiongwei. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patients[J]. Am J Pathol, 2008(173):470–482 41 Wang Xinglong, Su Bo, Sandra L. Siedlak ,et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins[J]. Proc Natl Acad Sci USA, 2008(105):19318–19323 42 Cho Dong-Hyung, Tomohiro Nakamura, Fang Jianguo,et al. S- nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury[J]. Science,2009,324(5923): 102-105 43 Deng Hansong, Mark W Dodson, Huang Haixia,et al. The Parkinson’s disease genes pink1 and pakin promote mitochondrial fission and/or inhibit fusion in Drosophila[J]. Proc Natl Acad Sci U S A,2008,105( 38): 14503-14508 44 Zhang Juan, Liu Wweihua, Liu Jianchao,et al. G protein β2 subunit interacts with mitofusin 1 to regulate mitochondrial fusion[J]. Nature Communication, 2010(1):101-110 |
[1] | XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8. |
[2] | SUN Li-cong, ZHANG Dan-shen.Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37. |
[3] | WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si.Current Situation and Prospect of Alzeimer’s Disease Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42. |
[4] | ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia.Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64. |
[5] | HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64. |
[6] | ZHANG Hao-ting, SONG Gui-qin, CUI Ruo-tong, HAO Min, WANG Wen-dong.Mining Target Genes of Alzheimer’s Disease Associated with Biological Clock by Bioinformatics Analysis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 1-7. |
[7] | YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong.Research Progress in Drug Treatment of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53. |
[8] | ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46. |
[9] | YANG-Lin,AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64. |
[10] | ZHANG Shuai,AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20. |
[11] | 王奇.Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease[J]. Acta Neuropharmacologica, 2018, 8(5): 71-72. |
[12] | CUI Su-ying, SONG Jin-zhi, CUI Xiang-yu, HU Xiao, DING Hui, YE Hui, ZHANG Yong-he.Intracerebroventricular Streptozocin-induced Alzheimer’s Disease-like Sleep Disorders: Role of the GABAergic System in the Parabrachial Complex[J]. Acta Neuropharmacologica, 2018, 8(5): 96-97. |
[13] | YU Li-li1,2,XU Li1,WANG Yi-nuo1,XUE Lu-ning1,Gou Ji-wei1,LI Hong-bo1,HOU Xue-qin1*,ZHANG Han-ting1*.Effects of Osthole on Learning and Memory and the Estrogen Pathway in Ovariectomized Rats[J]. Acta Neuropharmacologica, 2018, 8(4): 7-8. |
[14] | SHEN li-xia1,LIU Liang-liang1,ZHANG Ming1,LIU Yang1,ZHANG Dan-shen 2*.Research of Quercetin’s Estrogen-Like Action on Central Nervous System and Its Mechanisms[J]. Acta Neuropharmacologica, 2018, 8(4): 23-25. |
[15] | WANG Hao1, ZHANG Fang-fang1, FU Hua-rong1, ZHOU Yan-meng1, LIU Xin1, HOU Xue-qin 1, HU Wei2, Rolf Hansen2, XU Ying3, James O’Donnell3, ZHANG Han-ting1,2.Targeting PDE4 for Alzheimer’s Disease and Alcoholism: An implication in Alcohol-Related Dementia?[J]. Acta Neuropharmacologica, 2018, 8(4): 39-41. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||